Reata Pharmaceuticals Inc

Blackstone Inc.

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

340,793

Value ($000)

34,747

Weight

0.2%

2020 Q2 - 2023 Q2 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	34,747	0.2%	340,793	6/30/2023
2023 Q1	5/15/2023	30,985	0.1%	340,793	3/31/2023
2022 Q4	2/14/2023	12,947	0.0%	340,793	12/31/2022
2022 Q3	2/10/2023	8,564	0.0%	340,793	9/30/2022
2022 Q2	8/15/2022	10,357	0.0%	340,793	6/30/2022
2022 Q1	5/16/2022	11,164	0.0%	340,793	3/31/2022
2021 Q4	2/14/2022	8,987	0.0%	340,793	12/31/2021
2021 Q3	1/28/2022	34,287	0.1%	340,793	9/30/2021
2021 Q2	8/18/2021	48,232	0.1%	340,793	6/30/2021
2021 Q1	5/19/2021	33,977	0.1%	340,793	3/31/2021
2020 Q4	2/16/2021	42,129	0.2%	340,793	12/31/2020
2020 Q3	11/16/2020	23,240	0.1%	238,555	9/30/2020
2020 Q2	8/18/2020	43,543	0.2%	279,085	6/30/2020